Acoziborole

Generic Name
Acoziborole
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C17H14BF4NO3
CAS Number
1266084-51-8
Unique Ingredient Identifier
2IOR2OO3GW
Background

SCYX-7158 has been used in trials studying the treatment of Trypanosomiasis, Parasitic Diseases, Protozoan Infections, and Trypanosomiasis, African.

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

DDI Study of Single Oral Dose of Acoziborole With Sequential Co-administration of Midazolam and Dextromethorphan

First Posted Date
2023-07-17
Last Posted Date
2023-07-17
Lead Sponsor
Drugs for Neglected Diseases
Target Recruit Count
20
Registration Number
NCT05947604
Locations
🇲🇾

Clinical Research Center (CRC) Ampang Hospital, Kuala Lumpur, Malaysia

Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients

First Posted Date
2022-06-27
Last Posted Date
2022-08-19
Lead Sponsor
Drugs for Neglected Diseases
Target Recruit Count
35
Registration Number
NCT05433350
Locations
🇨🇩

HGR Bagata, Bagata, Kwilu, Congo, The Democratic Republic of the

🇨🇩

Hospital of Masi-Manimba, Masi-Manimba, Kwilu, Congo, The Democratic Republic of the

🇨🇩

Hôpital Général de Dipumba, Mbuji-Mayi, Kasai-Oriental, Congo, The Democratic Republic of the

and more 2 locations

Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects

First Posted Date
2022-02-25
Last Posted Date
2023-08-07
Lead Sponsor
Drugs for Neglected Diseases
Target Recruit Count
1208
Registration Number
NCT05256017
Locations
🇨🇩

General Referral Hospital of Bagata, Kwilu, Bandundu, Congo, The Democratic Republic of the

🇨🇩

General Referral Hospital of Kwamouth, Kwamouth, Mai-Ndombe, Congo, The Democratic Republic of the

🇨🇩

General Hospital of Bandundu, Bandundu, Congo, The Democratic Republic of the

and more 4 locations
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy